Haqq Christopher

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
35
Insider Sells Sum
$9.86M

Insider Activity of Haqq Christopher

The largest sale of all time was on 2018-05-15 and amounted to 25775 shares of Atara Biotherapeutics, Inc. for $1.17M.

Biography of Haqq Christopher

No biography is available at this moment.

2019-02-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
775
0.0016%
$39.59$30,682-61.38%
2019-02-11SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
13,975
0.0302%
$38.55$538,736-58.97%
2019-02-06SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
12,375
0.0269%
$38.62$477,922-58.44%
2018-11-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
775
0.0017%
$33.81$26,203-33.08%
2018-09-26SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
13,500
0.0304%
$43.08$581,580-18.65%
2018-09-25SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
13,500
0.0277%
$40.51$546,905-21.2%
2018-09-24SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
18,000
0.0389%
$39.91$718,425-15.65%
2018-08-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
775
0.0018%
$37.54$29,094-0.33%
2018-05-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
25,775
0.0573%
$45.30$1.17M-16.67%
2018-03-26SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
18,327
0.0448%
$39.79$729,265-5.35%
2017-11-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
1,604
0.0051%
$13.36$21,429+177.5%
2017-10-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0198%
$14.35$86,100+167.01%
2017-09-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0192%
$15.30$91,800+141.53%
2017-08-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
7,604
0.0258%
$14.75$112,159+157.89%
2017-07-17SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0187%
$14.92$89,520+77.14%
2017-06-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
6,000
0.0211%
$12.65$75,900+31.5%
2017-05-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
15,208
0.0508%
$14.99$227,968+0.33%
2017-04-17SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
12,000
0.0401%
$17.28$207,360-13.84%
2017-03-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
12,000
0.0429%
$19.60$235,200-19.1%
2017-02-15SaleAtara Biotherapeutics, Inc.
ATRA
EVP, R&D & Chief Scientific Of
15,208
0.0504%
$15.49$235,572-5.28%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.